Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › PlexBio Receives CE Mark for Fluorescence Analyzer

PlexBio Receives CE Mark for Fluorescence Analyzer

Aug 28, 2017
|
staff reporter

NEW YORK (360Dx) – PlexBio said today that it has received CE marking for a second-generation fluorescence analyzer, the PlexBio 100, which captures "distinct image patterns" recognized by bright-field microscopy and measures fluorescence-signal intensity by dark-field microscopy.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

  2. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

  3. BARDA Awards $684K to Luminex for Enhanced COVID-19 Multiplex Antibody Test

  4. Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test

  5. CDC Reverses Position, Says Asymptomatic Patients Should Be Tested for SARS-CoV-2

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.